Intensive care medicine research agenda on invasive fungal infection in critically ill patients-Reference-Cited by-同舟云学术

Intensive care medicine research agenda on invasive fungal infection in critically ill patients

Published:2017-03-02 Issue:9 Volume:43 Page:1225-1238
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

Bassetti Matteo^ORCID,Garnacho-Montero Jose,Calandra Thierry,Kullberg Bartjan,Dimopoulos George,Azoulay Elie,Chakrabarti Arunaloke,Kett Daniel,Leon Cristobal,Ostrosky-Zeichner Luis,Sanguinetti Maurizio,Timsit Jean-Francois,Richardson Malcom D.,Shorr Andrew,Cornely Oliver A.

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/article/10.1007/s00134-017-4731-2/fulltext.html

Reference88 articles.

1. Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M et al (2014) ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 20(Suppl 3):5–26

2. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z et al (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34(1):7–14

3. de Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46(12):1813–1821

4. Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT et al (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356(4):348–359

5. Reboli AC, Rotstein C, Pappas PG, Chapman SW, Kett DH, Kumar D, Betts R, Wible M, Goldstein BP, Schranz J et al (2007) Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356(24):2472–2482

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of petroselinic acid with in vitro and in vivo antifungal activity by targeting fructose-1,6-bisphosphate aldolase;Phytomedicine;2024-10

2. Fungal Pneumonia in a Diabetic Female Masquerading as Primary Lung Cancer;Journal of Global Infectious Diseases;2024-08-07

3. Global Epidemiology of Invasive Infections by Uncommon Candida Species: A Systematic Review;Journal of Fungi;2024-08-07

4. The Aspergillus galactomannan Ag VIRCLIA® Monotest and the sõna Aspergillus galactomannan lateral flow assay show comparable performance for the diagnosis of invasive aspergillosis;Mycoses;2024-08

5. A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study;Mycoses;2024-08